AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 2:15 p.m. PT (5:15 p.m. ET). Executives from AbCellera will present, with a live audio webcast available on the company's Investor Relations website. A replay will be accessible after the presentation. AbCellera is a technology company focused on analyzing natural immune systems to discover antibodies for drug development, collaborating with pharmaceutical and biotechnology firms to expedite and enhance their drug development processes.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005877/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera presenting at the J.P. Morgan Healthcare Conference?

AbCellera will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 2:15 p.m. PT.

How can I access AbCellera's presentation at the conference?

A live audio webcast of AbCellera's presentation can be accessed through the Investor Relations website.

What is the stock symbol for AbCellera?

The stock symbol for AbCellera is ABCL.

What does AbCellera specialize in?

AbCellera specializes in searching and analyzing natural immune systems to find antibodies for drug development.

Who are AbCellera's partners in drug development?

AbCellera partners with both large pharmaceutical companies and small biotechnology firms.